TrialBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie2021

Tocilizumab combined with favipiravir in the treatment of COVID-19: A multicenter trial in a small sample size.

Hong Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.